Table 3.
Survival for HHD patients and matched IHD and PD patients
| Overall survival | |||
| With censoring only at end of study | |||
| HHD | IHD | PD | |
| Median (IQR) years | 18.5 (10.4-NAa) |
11.9 (3.8- NAa) |
15.0 (5.1- NAa) |
| Comparison with HHD (p value) | – | < 0.001 | 0.002 |
| Mean years | 16.6 | 12.5 | 13.8 |
| With censoring at end of study and recovered native renal function | |||
| HHD | IHD | PD | |
| Median (IQR) years | 18.5 (10.4- NAa) |
12.0 (3.8- NAa) |
15.1 (5.1- NAa) |
| Comparison with HHD (p value) | – | < 0.001 | 0.003 |
| Mean years | 16.5 | 12.6 | 13.9 |
| Survival on initial RRT only | |||
| With censoring at all changes from the initial modality | |||
| HHD | IHD | PD | |
| Median (IQR) years |
NAb (8.4-NA) |
6.3 (2.9–11.5) |
6.1 (3.2–6.6) |
| Comparison with HHD (p value) | – | < 0.001 | < 0.001 |
| Mean years | 9.8 | 8.2 | 7.3 |
| Survival on dialysis treatment only | |||
| With censoring at renal transplantation, recovered native renal function and end of study | |||
| HHD | IHD | PD | |
| Median (IQR) years |
8.4 (6.7–10.7) | 6.2 (2.9–11.4) | 5.2 (3.1–7.5) |
| Comparison with HHD (p value) | – | 0.001 | < 0.001 |
| Mean years | 8.1 | 8.0 | 6.4 |
a Not Available, survival > 25% at end of follow up
bNot Available, survival > 50% at end of follow up